Your browser doesn't support javascript.
loading
Cabozantinib in patients with advanced Ewing sarcoma or osteosarcoma (CABONE): a multicentre, single-arm, phase 2 trial.
Italiano, Antoine; Mir, Olivier; Mathoulin-Pelissier, Simone; Penel, Nicolas; Piperno-Neumann, Sophie; Bompas, Emmanuelle; Chevreau, Christine; Duffaud, Florence; Entz-Werlé, Natacha; Saada, Esma; Ray-Coquard, Isabelle; Lervat, Cyril; Gaspar, Nathalie; Marec-Berard, Perrine; Pacquement, Hélène; Wright, John; Toulmonde, Maud; Bessede, Alban; Crombe, Amandine; Kind, Michèle; Bellera, Carine; Blay, Jean-Yves.
Afiliación
  • Italiano A; Early Phase Trials and Sarcoma Unit, Institut Bergonié, Bordeaux, France; University of Bordeaux, Bordeaux, France. Electronic address: a.italiano@bordeaux.unicancer.fr.
  • Mir O; Department of Medicine, Institut Gustave Roussy, Villejuif, France.
  • Mathoulin-Pelissier S; Unité d'épidémiologie et de recherche cliniques, Institut Bergonié, Bordeaux, France; Inserm UMR 1219, Équipe Epicene, Bordeaux, France; Inserm CIC-EC 1401, Bordeaux, France.
  • Penel N; Department of Medical Oncology, Centre Oscar Lambret, University of Lille, Lille, France.
  • Piperno-Neumann S; Department of Medicine, Institut Curie, Paris, France.
  • Bompas E; Department of Medicine, Institut Cancerologie de l'Ouest, Nantes, France.
  • Chevreau C; Department of Medicine, Oncopole, Toulouse, France.
  • Duffaud F; Department of Medical Oncology, Assistance Publique des Hôpitaux de Marseille, Hôpital La Timone, Marseille, France.
  • Entz-Werlé N; Department of Tumor Pediatrics, University Hospital Centre of Strasbourg, Strasbourg, France.
  • Saada E; Department of Medicine, Centre Antoine Lacassagne, Nice, France.
  • Ray-Coquard I; Department of Medicine, Centre Leon Berard, Lyon, France.
  • Lervat C; Department of Tumor Pediatrics, Centre Oscar Lambret, University of Lille, Lille, France.
  • Gaspar N; Department of Tumor Pediatrics, Institut Gustave Roussy, Villejuif, France.
  • Marec-Berard P; Department of Tumor Pediatrics, Centre Leon Berard, Lyon, France.
  • Pacquement H; Department of Tumor Pediatrics, Institut Curie, Paris, France.
  • Wright J; Cancer Therapy Evaluation Program (CTEP), Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA.
  • Toulmonde M; Early Phase Trials and Sarcoma Unit, Institut Bergonié, Bordeaux, France.
  • Bessede A; Immusmol, Bordeaux, France.
  • Crombe A; Department of Imaging, Institut Bergonié, Bordeaux, France.
  • Kind M; Immusmol, Bordeaux, France.
  • Bellera C; Unité d'épidémiologie et de recherche cliniques, Institut Bergonié, Bordeaux, France; Inserm CIC-EC 1401, Bordeaux, France.
  • Blay JY; Department of Medicine, Centre Leon Berard, Lyon, France.
Lancet Oncol ; 21(3): 446-455, 2020 03.
Article en En | MEDLINE | ID: mdl-32078813

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Piridinas / Sarcoma de Ewing / Neoplasias Óseas / Osteosarcoma / Inhibidores de Proteínas Quinasas / Anilidas Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Piridinas / Sarcoma de Ewing / Neoplasias Óseas / Osteosarcoma / Inhibidores de Proteínas Quinasas / Anilidas Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article Pais de publicación: Reino Unido